Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04009382 · ClinicalTrials.gov registry record · NA
Modulation Effects of Baduanjin Exercise on Subjective Cognitive Decline
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT04009382: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04009382 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 124 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04009382, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
The aim of this study is to investigate the modulation effects of Baduanjin (BDJ), a simple and innovative mind-body exercise, on cognitive function, resting state functional connectivity, and brain morphometry in individuals with subjective cognitive decline (SCD). The results obtained will provide novel insights for improving the prevention of age-related cognitive decline and Alzheimer's disease.
Interventions
- OTHER Baduanjin Exercise
- OTHER Cognitive Fitness Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2020-08-31 |
| Est. Completion | 2025-02-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04009382
The ClinicalTrials.gov registry entry for NCT04009382 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Baduanjin Exercise is the first listed.
NCT04009382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04009382 about?
NCT04009382 is a clinical study titled "Modulation Effects of Baduanjin Exercise on Subjective Cognitive Decline". The aim of this study is to investigate the modulation effects of Baduanjin (BDJ), a simple and innovative mind-body exercise, on cognitive function, resting state functional connectivity, and brain morphometry in individuals with subjective cognitive decline (SCD). The results obtained will provide...
What is the current status of trial NCT04009382?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2020-08-31. Estimated completion is 2025-02-06.
What interventions are being tested in trial NCT04009382?
The interventions under investigation include: Baduanjin Exercise (OTHER), Cognitive Fitness Program (OTHER).
Who is sponsoring clinical trial NCT04009382?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.